57619-29-1 Usage
General Description
The chemical compound "(E)-N-hydroxy-1-(1-methyl-1,6-dihydropyridin-2-yl)methanimine hydrochloride (1:1)" is a hydrochloride salt derivative of N-hydroxy-1-(1-methyl-1,6-dihydropyridin-2-yl)methanimine. It is an important organic compound with potential pharmaceutical applications. (E)-N-hydroxy-1-(1-methyl-1,6-dihydropyridin-2-yl)methanimine hydrochloride (1:1) is typically used as an intermediate in the synthesis of other chemical compounds, particularly in the development of pharmaceuticals and agrochemicals. Its unique molecular structure and properties make it a valuable building block for the creation of new drugs, as it can be modified to produce derivatives with specific therapeutic effects. Additionally, the hydrochloride salt form of this compound enhances its stability and solubility, making it more suitable for various pharmaceutical formulations.
Check Digit Verification of cas no
The CAS Registry Mumber 57619-29-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,6,1 and 9 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 57619-29:
(7*5)+(6*7)+(5*6)+(4*1)+(3*9)+(2*2)+(1*9)=151
151 % 10 = 1
So 57619-29-1 is a valid CAS Registry Number.
57619-29-1Relevant articles and documents
Novel pro-drug derivatives of pyridinium aldoxime type cholinesterase reactivators and method of using same
-
, (2008/06/13)
There is provided, novel pro-drug forms of pyridinium aldoxime type cholinesterase reactivators, namely, dihydropyridinium aldoximes, having the formula: SPC1 Wherein R represents a member selected from the group consisting of an alkyl (C1 -C4) group, a SPC2 Group, a SPC3 Group, SPC4 Group, and a SPC5 Wherein Z represents a member selected from the group consisting of a --CH2 --CH2 -- group, a --CH2 --O--CH2 -- group, a --CH2 CH2 OCH2 CH2 -- group, and a --CH2 O--CH2 --CH2 --O--CH2 -- group; wherein R1 represents a member selected from the group consisting of a hydrogen atom, a methyl group, an acyl group and a EQU1 group; and wherein X- represents an anion derived from a pharmaceutically acceptable acid addition salt. These compounds are useful in reactivating cholinesterase, inhibited following exposure to and/or ingestion of conventional anti-cholinesterase agents, especially in the brain.
